Moberg Pharma AB (publ) (STO: MOB) Stock Analysis & Fundamentals

MOBMoberg Pharma AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · mobergpharma.se

11.30SEK-0.18%Mkt Cap: 51.09M $P/E: —Today

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly k…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap51.09M $

Enterprise Value47.29M $

Revenue (TTM)0 $

Gross Profit734.61K $

Net Income (TTM)-2.61M $

Revenue/Share0.0000 USD

Last Price11.30 SEK

Fiscal Year EndDec 2025

MR QuarterDec 2020

Employees11

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-55.60

PEG—

EV/EBITDA-23.96

EV/Revenue—

P/SInfinity

P/B0.57

EPS (TTM)-0.46

EPS (Forward)-0.20

52W Range

7.53057% of range14.12

52W High14.12 SEK

52W Low7.530 SEK

Profitability

Gross Margin56.73%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin-201.18%

ROE-4.09%

ROA-3.99%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.67M $

CapEx (TTM)4.13M $

FCF Margin—

FCF Yield—

Net Debt-1.14M $

Net Debt/EBITDA0.58

Balance Sheet

Debt/Equity0.00

Current Ratio2.09

Quick Ratio0.27

Book Value/Sh19.53 SEK

Cash/Share0.4380 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateNov 4, 2019

Pay Date—

Splits

Last Split1:10

Split DateMay 24, 2023

Analyst Consensus

Rating0.0 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)16.00 SEK

Upside (mean)+41.6%

Target Range16.00 SEK – 16.00 SEK

# Analysts1

Ownership

Shares Out.47.18M

Float40.40M

Insiders11.88%

Institutions27.17%

Technical

SMA 509.762 (+15.8%)

SMA 2009.934 (+13.7%)

Beta0.64

S&P 52W Chg18.16%

Avg Vol (30d)54.53K

Avg Vol (10d)158.97K

Technical Indicators

RSI (14)64.7

MACD0.4926

MACD Signal0.3359

MACD Hist.+0.1566

BB Upper11.97 SEK

BB Middle10.21 SEK

BB Lower8.461 SEK

BB Width34.34%

ATR (14)0.4690 SEK

Vol Ratio (20d)0.63x